COMP <GO>
XRAY vs NVCR // FORWARD P/E MULTIPLE
DENTSPLY SIRONA Inc. (NASDAQ) VS. NovoCure Limited (NASDAQ) • 15-METRIC TALLY: XRAY 7
— NVCR 3
■ METRIC PARITY
LAST: $9.90 (+3.88%) • MKT CAP: $1.90B
forward-pe
—
LAST: $13.21 (+0.46%) • MKT CAP: $1.54B
forward-pe
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XRAY VS. NVCR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | XRAY | NVCR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 50.00% | 74.50% | -24.50 | NVCR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -11.00% | -27.50% | +16.50 | XRAY | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 12.27% | -4.96% | +17.23 | XRAY | /fcf-yield <GO> |
| Operating Margin | -11.50% | -23.50% | +12.00 | XRAY | /operating-margins <GO> |
| Net Profit Margin | -16.20% | -20.80% | +4.60 | XRAY | /net-margins <GO> |
| Revenue Growth (YoY) | -3.00% | 8.30% | -11.30 | NVCR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 6.68% | 0.00% | +6.68 | XRAY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 0.54 | -0.09 | NVCR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 6/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.6 | 34.3 | +20.30 | XRAY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.90B | $1.54B | $362.4M | XRAY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | XRAY REV | NVCR REV | XRAY GROSS % | NVCR GROSS % | XRAY FCF | NVCR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.68B | $655.4M | 50.0% | 74.5% | $235.0M | -$75.7M |
| FY 2024 | $3.79B | $605.2M | 51.6% | 77.3% | $461.0M | -$69.2M |
| FY 2023 | $3.96B | $509.3M | — | — | $377.0M | -$73.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XRAY // BETA —
NVCR // BETA —